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Stimulation either in vivo or in vitro by any of a  number of biological or 
chemical agents (1-3) will render macrophages (MOP)  1 non_specifically cytolytic 
for tumor target cells in vitro.  M~P  which have acquired such lytic activity 
have often been referred to as activated. By this operational definition, Mob 
recovered from certain neoplasms, for example regressing Moloney sarcomas 
(4), have been activated in vivo, as they will kill a wide variety of antigenically 
distinct tumor target cells when freshly explanted into culture. MoP  isolated 
from many tumors  have proved  to  be  inefficient killers,  however, or have 
lacked cytolytic activity entirely (5-7).  This can be the case even within the 
Moloney system as  Mob  obtained from progressing,  rather than regressing, 
sarcomas usually lack the ability to destroy tumor cells  (8). In view of the 
importance that cytolytic Mob within tumors could have in host defense against 
neoplasia,  the question of why Mob  from some tumors will kill,  while those 
from the majority will not, becomes an urgent one. The data to be presented 
here we believe are the first that directly begin to resolve this enigma. 
Mouse peritoneal MoP  elicited by the injection of thioglycollate broth (TG- 
M~p), will become cytotoxic for tumor target cells when they are exposed to 
microgram/milliliter  concentrations of bacterial lipopolysaccharide (LPS, endo- 
toxin) in vitro (3).  2 LPS concentrations in the microgram/milliliter range also 
have been shown to induce cytotoxicity in Mob  recovered directly from mouse 
or rat fibrosarcomas (5). Thus,  under appropriate conditions LPS  is able to 
activate Mob from a variety of sources. We will show, however, that a distinct 
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difference in LPS-responsiveness exists between peritoneal and tumor MoP, the 
latter being much more sensitive to stimulation. Evidence that such heightened 
responsiveness is indicative of an important functional change which develops 
in tumor MoP, and that this change enables these primed cells to respond to a 
final signal or combination of signals by becoming cytolytic, will be provided. 
Finally, we will show that MoP in progressing sarcomas, at least those studied 
here, are noncytolytic because they have been activated only partially, rather 
than  fully,  and  not because  there  is  a  total  absence  of Mdp  stimulation  in 
neoplasms. 
Materials and Methods 
Tumor Systems.  The  mice  used  were  6-  to  10-wk-old  BALB/c  AnCr males.  Tumors  were 
induced by intramuscular (gastrocnemius) injection of either cultured MSC (Moloney sarcoma of 
BALB/c origin) cells (9) or 3T3 cells transformed by SV40 virus (10) contained in 20/~l of HEPES- 
buffered  (15  mM)  Eagle's  minimum  essential  tissue  culture  medium  (H-MEM).  As  shown 
previously  (11),  most  mice  injected  with  5  ×  103  MSC  cells  develop  tumors  which  regress 
spontaneously,  while  inoculation  of  108  MSC  cells  causes  neoplasms  which  are  invariably 
progressive  and lethal.  All tumorigenic doses of SV40-3T3  cells  (here  105) produce  neoplasms 
which grow  inexorably.  For these experiments sarcomas  were harvested aseptically either 11 
(regressing) or 14 (progressing) days postinoculation, except where indicated otherwise. 
Tumor Disaggregation.  As  described  in  detail  elsewhere  (12),  tumors  were  minced  and 
disaggregated by repeated exposure to a  stirred mixture of trypsin (2.5% solution, Grand Island 
Biological Co., Grand Island, N.Y.), crude collagenase (CLS II, 179 U/mg, Worthington Biochem- 
ical Corp.,  Freehold, N.J.),  and deoxyribonuclease (DNAse I, B grade,  1.2  x  105 dornase U/mg, 
Calbiochem, San Diego, Calif.). The former two enzymes were used at concentrations of 0.1 mg/ 
ml,  and the DNAse at 0.025 mg/ml.  After discarding the first two harvests (which eliminated 
most  dead  cells  and  debris),  cells  freed  from  fragments  were  centrifuged  out  of the  enzyme 
solution  at  20-rain intervals and held  pooled  in ice-cold  H-MEM  containing 10%  fetal bovine 
serum (FBS, Flow Laboratories, Inc., Rockville, Md.). 
Cytotoxicity Assay.  Me in cell suspensions derived from tumors were established in monolay- 
ers, as reported previously (4).  Briefly, 2.5 ×  10  e cells in 0.5 ml H-MEM +  10% FBS were seeded 
into each of the 16-mm diameter, flat-bottemed wells of plastic LINBRO plates (Flow Laborato- 
ries, Inc.). After 5 min the plates were vigorously shaken to resuspend nonadherent cells, after 
which another 5 min of incubation was allowed.  Plates were again shaken after a  total elapsed 
time of 10 rain and the supernatant medium containing nonadherent cells was aspirated.  The 
entire procedure was repeated twice more. After the third plating, between 0.6 and 1 ×  10  ~ cells 
usually remained adherent to the plastic.  This determination was made by direct counting of 
methanol-fixed, Giemsa-stained cells in representative wells. A microscope ( x  400 magnification) 
equipped  with  an  ocular  grid  of known  area  was  used  for counting.  Variability in total  cell 
number well-to-well was <10%. M(P population density (McP/mm  ~) is used throughout this paper 
to characterize monolayers, rather than the total number of M¢/well or the ratio of MoP to target 
cells, because the density of Mdp in monolayers has been shown to be one of the most important 
culture variables influencing killing. 2 The percentage of Mdp  in monolayers was determined by 
counting the total number of phagocytic cells in wells to which zymosan had been added before 
fixation,  and correcting for polymorphonuclear leukocytes.  Effector  cell  populations  prepared 
from Moloney sarcomas always contained >80% Mdp, and usually >90%, while those from SV40- 
3T3  sarcomas were  >70%.  The most common contaminating cell types,  which previously have 
been shown not to interfere with the assay of Mdp-mediated cytotoxicity  (4),  were,  in order of 
frequency, tumor cells, pelymorphonuclear leukocytes, and rare T lymphocytes. 
As before (4), release of 51Cr from prelabeled P815 mastocytoma cells was used as the measure 
of M¢-mediatod killing. These targets are antigenically unrelated to the MSC or SV40-3T3 cells 
used  to  induce  tumors  and  therefore  were  insusceptible  to  specific  killing  by  the  rare  T 
lymphocyte which contaminated monolayers, (13). Monolayers were examined microscopically at 
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remaining.  The results of these visual evaluations correlated inversely with the percentage of 
s~Cr released during the assay period. Assay wells were set up in triplicate for each sample as 
follows: 0.5 ml of H-MEM +  60% FBS, then 0.5 ml of H-MEM with or without an appropriate 
concentration of LPS,  followed by 0.5 ml H-MEM  +  30%  FBS containing 10  s prelabeled target 
cells. The final FBS concentration in a  total vol of 1.5  ml was 30%.  After 16 h, the contents of 
each well were mixed by drawing 1 ml of the total volume up and down once in an automatic 
pipette (Selectapette, Clay Adams, Inc. Div. of Becton, Dickinson & Co., Parsippany,  N.J.), after 
which  1  ml  was  removed  and  centrifuged to eliminate  cells.  A  0.5-ml  aliquot of centrifuged 
supernate was removed from these samples for counting in a  gamma scintillation spectrometer. 
Results are reported as percent specific 51Cr release, calculated as follows: 
Experimental release -  spontaneous release  )<  100 
Total release (freeze-thaw 3 times) -  spontaneous release 
Spontaneous  release  of s~Cr  (1.5-2%  per hour)  was that  which occurred from prelabeled  P815 
mastocytoma cells incubated during the assay period on monolayers of TG-M¢. 
Bacterial LPS.  Purified LPS for these experiments was provided by Dr. David C. Morrison 
(Scripps  Clinic  and  Research  Foundation).  Preparation  of this  phenol-extracted,  lipid A-rich 
molecule (fraction II) from Escherichia coli serotype 0111:B4  (ATCC 12015) has been described 
(14).  Quantification of LPS was accomplished by using a  modification (14) of the colitose assay 
first described by Cynkin and Ashwell (15). 
Results 
Effect  of LPS on  Mdp  Isolated  from Regressing  Moloney  Sarcomas.  The 
TG-M~ of BALB/c mice are relatively refractory to in vitro activation by LPS; 
at least levels of killing mediated by these cells are lower than those which can 
be attained by using the TG-Mdp of many other strains, for example, C57BL/62 
We therefore wanted to ascertain first whether or not the M¢  isolated from 
tumors of BALB/c mice were similarly refractory. M¢ monolayers were estab- 
lished from  ll-day-old regressing Moloney sarcomas and  immediately chal- 
lenged with target cells, with or without added LPS (10/~g/ml). 51Cr release in 
unstimulated  cultures  was  41%, while  that  obtained  from  LPS-stimulated 
monolayers was 84%. Visual examination of the cultures confirmed that the 
greatest degree of killing had  occurred in  the  wells  which contained both 
tumor M¢P  and LPS. In a  series of nine experiments conducted under similar 
conditions,  TG-Mq) obtained  from  normal  BALB/c  mice  gave  a  mean  (± 
standard  deviation)  slCr  release  of 11  ±  8%.  Based  on  these  data  it  was 
concluded that, unlike M¢ obtained from thioglycollate-stimulated peritoneal 
cavities, MoP isolated from regressing Moloney sarcomas of BALB/c mice were 
highly responsive to stimulation by LPS. 
To determine the smallest amount of LPS that would enhance killing by 
regressor Mqb, and thus their degree of LPS-sensitivity, a dose-response assay 
was  performed over  a  concentration range  of  10  fg  to  10  ~g/ml.  Fig.  l a 
illustrates that at a Mq) population density of 6 ×  103 MdP/mm  2 LPS concentra- 
tions _> 1 ng/ml gave maximal stimulation, with the linear portion of the dose- 
response curve falling in the picogram/milliliter range.  By comparison, TG- 
M¢ similarly exposed to LPS failed to kill, except to a slight degree at an LPS 
concentration of 10 ~g/ml. 
Effect  of LPS  on  Regressor  Mdp  Which  Had  Lost  Cytolytic  Activity  In 
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Fro.  1.  M~p  from  an  ll-day,  regressing  Moloney  sarcoma  were  seeded  into  wells  and 
either challenged immediately with 10  ~ P815 mastocytoma target cells in the absence or 
presence of various concentrations of LPS,  or they were  held  in culture  for 24 or  72 h 
before cytotoxicity was assayed.  1 a. Immediate challenge. Effect of increasing concentra- 
tions  of  LPS  added  either  to  monolayers  consisting  of tumor  Mob  (O---O)  or  TG-M¢b 
obtained from normal mice (O--<>).  Only tumor Mob responded, the linear portion of the 
LPS  dose-response  curve  being  found  in  the  picogram  to  nanogram/milliliter  range. 
Without added LPS, tumor M~b effected 46%-specific 51Cr release, while 0% was obtained 
by using TG-M~b.  1 b.  After 24 h  in culture.  Capacity of the tumor M¢  to kill without 
additional stimulation had been lost: 51Cr release was 0% at LPS concentrations -< 100 pg/ 
ml. LPS sensitivity was pronounced.  1 e. After 72 h  in culture, with supernatant medium 
having been replaced after 48 h.  51Cr release was 5% without LPS,  or at concentrations 
<- 100 pg/ml. A similar result was obtained in a  separate experiment after tumor MoP had 
been held in culture for 96 h  (two medium changes) before target cells and LPS were added. 
Vitro.  M¢P derived from regressing sarcomas lose their capacity to kill tumor 
cells after 24-48 h in culture (4). To determine whether such formerly cytotoxic 
MoP remain sensitive to minute amounts of LPS or, functionally became more 
like  poorly  responsive  TG-McP,  monolayers  were  established  from  ll-day 
regressing  Moloney sarcomas and cultured for various times before they were 
exposed to LPS  and  challenged  with target cells.  Monolayers  were insignifi- 
cantly cytolytic after 24 and 72 h in vitro, unless they were stimulated by LPS 
(Figs.  1 b and 1 c). The concentration which induced maximal cytolytic activity 
was 10 ng/ml, slightly more than the amount that was needed to induce freshly 
explanted regressor M¢ to kill at peak levels (Fig.  1 a). It is difficult to ascribe 
significance to this difference, however, because monolayers had diminished in 
M~b population density (from 6  x  103 to approximately 4 x  103/mm 2) during the 
periods of incubation in vitro. In a separate experiment (data not shown), such 
exquisite sensitivity to LPS remained a characteristic of regressor M~ held up 
to 96 h  in culture. RUSSELL,  DOE,  AND  McINTOSH  1515 
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FIG. 2.  LPS-stimulated killing  by M~  recovered from progeseing Moloney (C)--C))  and 
SV40-3T3 ((>--~>)  sarcomas.  In both instances LPS concentrations of  approximately 1 ng/ 
ml induced maximal killing  from the otherwise impotent progressor Mdp. 
Effect of LPS on MeP Recovered from Progressing  Sarcomas.  Even when 
challenged with target cells immediately after explantation, MoP from large, 
progressing  Moloney sarcomas are  inefficient killers,  compared with  those 
isolated from regressing sarcomas (8). MoP recovered from progressing sarcomas 
induced by SV40-3T3 cells are similarly impaired in their ability to kill in vitro 
(S. W. Russell, unpublished data). To determine their sensitivity to LPS, Me 
from each of these progressing sarcomas (both postinoculation day 14)  were 
established in vitro and separately challenged with tumor target cells, either 
in the absence or presence of various concentrations of LPS. As shown in Fig. 2, 
these progressor M~ developed the capacity to kill tumor target cells when they 
were exposed to the same concentrations of LPS that were effective in amplify- 
ing the cytolytic activity of Me derived from regressing Moloney sarcomas. 
Is  Heightened  Responsiveness  to  LPS a  Systemic  Phenomenon  in  Tumor- 
Bearing Mice?  To determine whether MoP throughout the bodies of tumored 
mice, or only those within the milieu of the neoplasm, were characterized by 
heightened LPS responsiveness we undertook a study of TG-McP elicited from 
mice bearing either regressing or  progressing Moloney sarcomas.  The  LPS 
responsiveness of these cells was compared either to  TG-M¢  obtained from 
normal mice or Me recovered directly from regressing Moloney sarcomas. Fig. 
3 shows that, in contrast to M¢ derived from tumors, LPS at concentrations up 
to 10 tsg/ml failed to induce significant cytolytic activity in any of the TG-McP 
populations. The presence of a  tumor elsewhere in the body therefore did not 
alter the pattern of LPS-responsiveness of peritoneal MoP. 
Kinetics  of  51Cr Release  from  Target  Cells  Injured  by  LPS-Stimulated 
M¢.  Sequential determinations were made of 51Cr released from target cells 
by either LPS-stimulated  (100 ng/ml)  or  unstimulated Me  freshly isolated 
from regressing Moloney sarcomas. The objective was to determine whether 
the release profiles for the two effector cell populations were basically the same 
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FIG.  3.  Heightened LPS-responsiveness was not a systemic phenomenon in tumor-bearing 
mice. Increasing concentrations of LPS were added to monolayers consisting of M~ from 7- 
to 14-day-old regressing Moloney sarcomas (O--O), or TG-M~ derived from normal mice 
(O--O), or mice with 7-14 day regressing ([]--[]) or progressing (A--A) Moloney sarcomas. 
Values are the means ±  standard deviations from nine separate experiments. 
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Fza. 4.  The specific  5~Cr  release mediated by M~  obtained from 11-day-old  regressing 
Moloney sarcomas  was assayed  sequentially,  either  with (O--O) or  without (O--O) 100  ng 
LPS added/ml. First  release  of  5~Cr  was detectable,  though barely, 4 h after  cells  were 
introduced. Thereafter 51Cr  in the supernatant media increased linearly  with respect  to 
time. The rate of  51Cr  release  was faster  in LPS-stimulated cultures,  accounting for the 
greater total  amount found at 16 h, compared to unstimulated cultures.  TG-M~  from 
normal mice (D--[])  produced  an  entirely  different  release  profile  at  an  LPS concentration 
(100 ~g/ml) 1,000  times greater than that used to stimulate tumor M~; lower LPS 
concentrations  would have had little  detectable  effect  on TG-M~. RUSSELL,  DOE,  AND  McINTOSH  1517 
leakage of radioisotope was first (although barely) detected 4 h after mastocy- 
toma cells were exposed to  M¢  monolayers and continued to  increase in  a 
linear fashion with respect to time. The rate of 51Cr release was increased with 
LPS present, accounting for the greater total amount of radiolabel which was 
found in the supernates of these cultures at 16 h. 
The release profile associated with normal TG-McP exposed for a similar time 
to  1,000 times the concentration of LPS  (100 /~g/ml) is included in Fig.  4 to 
illustrate further the dramatic difference which existed between these Me and 
those derived from tumors. A longer period of time (6-8 h) was needed before 
TG-McP gave detectable release of 51Cr from targets. Thereafter, radioisotope 
found in the supernates of cultures failed to increase in a  fashion similar to 
that observed in wells which contained tumor MoP. 
Discussion 
M¢  isolated from neoplasms may lack cytolytic activity (5-7),  suggesting 
either  that  they  are  not  fully  activated  or,  if  they  are,  that  their  lytic 
mechanism has been blocked in some way. The results of the studies reported 
here favor the first explanation. Noncytolytic  tumor M¢ were shown to be only 
partially activated or, as we prefer to describe them, primed. No evidence was 
found to support the alternative possibility of a blocked effector mechanism. 
The hallmark of the primed Mdp was exquisite sensitivity to stimulation by 
bacterial LPS: picogram to nanogram/milliliter concentrations of LPS rapidly 
induced primed Mq) to kill, but had no demonstrable effect on noncytolytic  TG- 
MoP derived either from normal or tumored mice. The finding that heightened 
LPS-sensitivity was not a  property of TG-M~  elicited from tumored animals 
indicates  that  priming  occurs,  at  least  in  part,  within  the  milieu  of the 
neoplasm,  rather than systemically. This finding complements and extends 
Hibbs' observation that full activation is a distinctly localized phenomenon (2). 
The primed state can thus be summarized as one in which a final signal, here 
supplied by LPS and perhaps given in conjunction with other stimuli  (e.g., 
lymphokines), will trigger the expression of cytolytic activity. 
The  fully activated state  was  evanescent in  culture;  naturally occurring 
cytolytic activity of MoP recovered from regressing Moloney sarcomas was lost 
within the first 24 h  spent in vitro. The capacity to kill tumor cells could be 
regained,  however,  if these  formerly cytolytic M¢  were exposed to  minute 
amounts  of  LPS.  The  fact  that  these  cells  could  still  be  induced  to  kill 
maximally by LPS a~r  as long as 96 h  in culture established that:  (a) they 
had  not  reverted to  the  level  of TG-Mdp during this  period,  i.e.  they had 
remained  primed;  and  (b)  the  primed  state,  by  comparison  to  the  fully 
activated one, was relatively stable. 
Based on these findings we propose that M¢ in tumors proceed through at 
least two stages on the way to full activation. The first stage incorporates the 
steps which lead to  priming,  and apparently is completed in tumor-bearing 
mice regardless of whether the neoplasm in question is regressing or progres- 
sing. These M& cannot kill without further stimulation. Under ideal conditions, 
the first stage undoubtedly forms a continuum with the second, leading to full 
activation and the development of cytolytic activity. The signal(s) required to 
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neously regressing Moloney sarcomas,  as  Mqb  recovered from those tumors 
were cytolytic. M¢ recovered from two different progressing sarcomas, on the 
other  hand,  could  not  kill,  but  were  primed.  This  finding  indicated  that 
progressor Me were unable to destroy tumor cells because they had failed to 
reach, or remain in, the fully activated state and not because there had been a 
complete absence of MoP stimulation in the face of tumor progression. The fact 
that cytolytic MoP  could be allowed to lose their activity in vitro and then be 
stimulated  to  kill  again  by  LPS  reinforces the  concept  that  the  pathway 
between primed and fully activated Mep is bidirectional and readily traversed 
in either direction. The long-term stability of primed M¢ in vitro, on the other 
hand, raises the question as to whether or not reversion to the level of the TG- 
M4p is possible. 
Further indirect evidence suggesting that activation is a  two stage process 
may be found by comparing the kinetic profiles of ~lCr release produced by 
cytolytic regressor MoP cultured with or without nanogram/milliliter amounts 
of LPS,  and  TG-M¢  in  which cytolytic activity was  induced,  de  novo,  by 
microgram/milliliter concentrations of LPS. The pattern of radioisotope release 
that characterized cytolysis mediated by tumor Mep was similar in the presence 
or absence of LPS:  ~lCr was first detectable 4 h  after prelabeled target cells 
were exposed to monolayers, and increased subsequently in supernates linearly 
with respect to time. Only the rates of 51Cr release (greater in LPS-stimulated 
cultures) differed. The profile obtained with TG-McP was very different: release 
did not begin for 6-8 h and thereafter did not follow linear kinetics. One of us 
has  shown,  however,  that  a  release  profile  essentially  identical  to  those 
described here for tumor M¢ can be obtained if TG-Mep are first preincubated 
with LPS  for  12-16 h  before cytolytic activity is measured.  ~ In light of the 
current findings,  we  would  view  the  need for  preincubation and  the  time 
required to complete stage one of the activation process, i.e. to prime the TG- 
MoP, as probably being one and the same. 
Similar results to those described here, derived from an entirely different 
system, have recently been reported by Hibbs et al.  (16). Rather than tumor- 
bearing mice, these authors used as their source of MoP  mice that had been 
chronically infected with either bacillus Calmette-Gudrin or Toxoplasma gon- 
dii.  Peritoneal MoP  elicited from these animals nonspecifically killed tumor 
cells, providing that fetal, rather than adult, bovine serum was used in the 
culture medium. The fact that killing did not occur in adult bovine serum, and 
was similarly undetectable in the presence of adult sera from a  number of 
other species, led these investigators to postulate that serum factors were able 
to modulate the cytolytic activity of activated MoP. Concentrations of crude 
endotoxin in the same range as the LPS concentrations used here were effective 
in overcoming the inhibition produced by adult bovine serum or, in separate 
experiments,  by  serum  fractions  (17). From  these  lines  of evidence these 
authors hypothesized the existence of a nontumoricidal, activated MoP, which 
would correspond to the noncytolytic MoP  we are describing as primed. They 
speculated further that nonimmunologic mechanisms in tumors might inhibit 
the triggering of cytolytic activity. 
We have independently reached nearly the same conclusions working with RUSSELL,  DOE,  AND  MCINTOSH  1519 
MoP  isolated from tumors; however, we differ slightly in our interpretation of 
the results. Both groups recognize the probable existence of agents which will 
trigger  or  augment  Mq)-mediated  cytolysis.  In  addition,  Hibbs  et  al.  (16) 
emphasize a  negative control mechanism, i.e.  one which actively suppresses 
the intrinsic cytolytic activity of an activated Mdp. It is here that we differ, as 
it is our concept that noncytolytic Mdp  in tumors arise,  not by subduing an 
otherwise cytolytic, activated MoP, but rather due to a stimulatory defect. Such 
a  defect could be either the lack of, or the interference with, stimulation. We 
contend that the primed Mdp  is a  stable  intermediate along the path to the 
more labile state of full activation,  and is  a  cell to which the activated Mdp 
returns passively  upon  the cessation or blocking  of appropriate  stimulation. 
Our observations that the cytolytic activity of regressor Me would decay in 
medium supplemented with FBS,  but could be regained almost immediately 
a~r  stimulation  with  small  amounts  of LPS,  would  seem to  support  this 
viewpoint. 
Such relatively minor differences in interpretation will have to be resolved 
through  additional  experimentation.  It  can be  said  now,  however,  that the 
basis findings are likely to be sound, as they have been made independently by 
two groups  working with two  different systems.  The  fact that  one of these 
systems utilized Me isolated directly from neoplasms has additionally increased 
the relevance these observations may have to cancer. 
Summary 
The state in  which macrophages (M¢)  from regressing Moloney sarcomas 
could kill tumor target cells was a  highly labile one which decayed rapidly in 
vitro. Thereal~er, regressor M¢ were noncytolytic. M¢ from several different 
progressing sarcomas failed to  kill,  even when challenged with target cells 
immediately al~r  explantation.  Similarly,  thioglycollate-induced peritoneal 
MoP  (TG-M¢) did not kill.  Noncytolytic M~  derived either from progressing 
sarcomas  or  from  long-term  (up  to  96  h)  cultures  of regressor  M¢  were 
exquisitely sensitive to stimulation by bacterial lipopolysaocharide (LPS): pico- 
gram/milliliter amounts induced killing. Similar concentrations of LPS had no 
demonstrable effect on TG-M¢.  Thus, tumor Mdp generally appeared to have 
been primed in vivo,  with those in regressing sarcomas having additionally 
acquired  cytolytic  activity.  Inability  of  progressor  MoP  to  kill  apparently 
stemmed from lack of, or failure to respond to,  the signal needed in vivo to 
trigger cytolytic activity, rather than the total absence of activation. 
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